© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Lifestyle Medicine Guidelines for T2D, Prediabetes Are the Result of Remarkable Collaboration Across Specialties
July 14, 2025
Lead author for the American College of Lifestyle Medicine's new clinical practice guideline discusses the broad endorsement for the recommendations across participating groups.
Obesity-Related Cancer Deaths More Than Tripled in the US from 1999 to 2020
July 14, 2025
ENDO 2025. Older adults, rural populations, and residents in the Midwest experienced the highest mortality rates, according to new data.
FDA to Review GSK's Application for Expanded Use of RSV Vaccine in High-Risk Adults Aged 18 to 49
July 14, 2025
GSK's RSV vaccine Arexvy would join shots from Pfizer and Moderna for the younger adult population, broadening choice for those with risk factors for severe disease.
FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data
July 14, 2025
FDA approval based on FINEARTS-HF trial showing 16% risk reduction in CV death and HF events.
AstraZeneca's Aldosterone Inhibitor Baxdrostat Effective Against Resistant HTN in Late-Stage Trial
July 14, 2025
Baxdrostat met the primary and all secondary endpoints, setting up a first regulatory filing for the selective aldosterone synthase inhibitor, according to AstraZeneca.
Treatment Options for Obesity-Related Cardiometabolic Diseases: Clinician Insights for Primary Care
July 11, 2025
Treatment should address root causes, including lifestyle modifications, stress management, and gut health, Monu Khanna, MD, told Patient Care.
Beyond Nutritional Deficiencies: Managing GLP-1 Side Effects With Lifestyle Interventions
July 11, 2025
Jonathan Bonnet, MD, MPH, discusses common side effects of GLP-1 medications for obesity and how nutritional and behavioral strategies can help mitigate them.
Machine Learning Predicts Subjective Cognitive Decline During Menopause: Novel Framework for Early Detection
July 11, 2025
Key predictors of the severity of self-reported cognitive complaints among nurses going through menopause included symptom severity and climacteric stage.
Elinzanetant Gets UK Nod for Moderate to Severe Vasomotor Symptoms in Menopause: Is the US Far Behind?
July 11, 2025
Bayer's elinzanetant gains UK approval as the first dual-action, nonhormonal treatment for menopausal symptoms.